Resources
Plasmid Files

pBABE-Zeo

Retroviral expression vector derived from the Moloney murine leukemia virus. Contains a Zeocin™ resistance marker.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pBABE-Zeo Sequence and MappBABE-Zeo.dna
Map and Sequence File   
Sequence Author:  Cell Biolabs
Download Free Trial Get SnapGene Viewer

 SspI (4777) XmnI (4572) ScaI (4453) PvuI (4343) FspI (4195) NotI (3852) DrdI (3181) AflIII - PciI (3073) BspQI - SapI (2957) BbsI (2821) BmtI (2203) AarI - BfuAI - BspMI (8) SpeI (616) Bsu36I (737) BstEII (1035) BsrGI (1230) BamHI (1355) BsaAI - SnaBI (1374) EcoRI (1379) SalI (1397) AccI (1398) NcoI (1634) SfiI (1680) StuI (1726) AvrII (1727) HindIII (1743) MauBI (1785) SgrAI (1863) BmgBI (1883) FseI (2025) DraIII (2102) BspDI - ClaI (2125) NheI (2199) pBABE-Zeo 4888 bp
SspI  (4777)
1 site
A A T A T T T T A T A A
XmnI  (4572)
1 site
G A A N N N N T T C C T T N N N N A A G
ScaI  (4453)
1 site
A G T A C T T C A T G A
PvuI  (4343)
1 site
C G A T C G G C T A G C
FspI  (4195)
1 site
T G C G C A A C G C G T
NotI  (3852)
1 site
G C G G C C G C C G C C G G C G
DrdI  (3181)
1 site
G A C N N N N N N G T C C T G N N N N N N C A G

Sticky ends from different DrdI sites may not be compatible.
AflIII  (3073)
1 site
A C R Y G T T G Y R C A

Sticky ends from different AflIII sites may not be compatible.
PciI  (3073)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
BspQI  (2957)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different BspQI sites may not be compatible.
SapI  (2957)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different SapI sites may not be compatible.
SapI gradually settles in solution, so a tube of SapI should be
mixed before removing an aliquot.
BbsI  (2821)
1 site
G A A G A C N N C T T C T G N N ( N ) 4

Sticky ends from different BbsI sites may not be compatible.
BbsI gradually loses activity when stored at -20°C.
BmtI  (2203)
1 site
G C T A G C C G A T C G
AarI  (8)
1 site
C A C C T G C ( N ) 4 G T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the AarI
recognition sequence.
Sticky ends from different AarI sites may not be compatible.
After cleavage, AarI can remain bound to DNA and alter its
electrophoretic mobility.
BfuAI  (8)
1 site
A C C T G C ( N ) 4 T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the BfuAI
recognition sequence.
Sticky ends from different BfuAI sites may not be compatible.
BfuAI is typically used at 50°C, but is 50% active at 37°C.
BspMI  (8)
1 site
A C C T G C ( N ) 4 T G G A C G ( N ) 4 ( N ) 4

Efficient cleavage requires at least two copies of the BspMI
recognition sequence.
Sticky ends from different BspMI sites may not be compatible.
SpeI  (616)
1 site
A C T A G T T G A T C A
Bsu36I  (737)
1 site
C C T N A G G G G A N T C C

Sticky ends from different Bsu36I sites may not be compatible.
BstEII  (1035)
1 site
G G T N A C C C C A N T G G

Sticky ends from different BstEII sites may not be compatible.
BstEII is typically used at 60°C, but is 50% active at 37°C.
BsrGI  (1230)
1 site
T G T A C A A C A T G T

BsrGI is typically used at 37°C, but is even more active at 60°C.
BamHI  (1355)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can
remain bound to DNA and alter its electrophoretic mobility.
BsaAI  (1374)
1 site
Y A C G T R R T G C A Y
SnaBI  (1374)
1 site
T A C G T A A T G C A T
EcoRI  (1379)
1 site
G A A T T C C T T A A G
SalI  (1397)
1 site
G T C G A C C A G C T G
AccI  (1398)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the
recognition sequence.
Sticky ends from different AccI sites may not be compatible.
NcoI  (1634)
1 site
C C A T G G G G T A C C
SfiI  (1680)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI
recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
StuI  (1726)
1 site
A G G C C T T C C G G A
AvrII  (1727)
1 site
C C T A G G G G A T C C
HindIII  (1743)
1 site
A A G C T T T T C G A A
MauBI  (1785)
1 site
C G C G C G C G G C G C G C G C
SgrAI  (1863)
1 site
C R C C G G Y G G Y G G C C R C

Efficient cleavage requires at least two copies of the SgrAI
recognition sequence.
BmgBI  (1883)
1 site
C A C G T C G T G C A G

This recognition sequence is asymmetric, so ligating blunt ends
generated by BmgBI will not always regenerate a BmgBI site.
FseI  (2025)
1 site
G G C C G G C C C C G G C C G G

FseI gradually loses activity when stored at -20°C.
DraIII  (2102)
1 site
C A C N N N G T G G T G N N N C A C

Sticky ends from different DraIII sites may not be compatible.
BspDI  (2125)
1 site
A T C G A T T A G C T A
ClaI  (2125)
1 site
A T C G A T T A G C T A
NheI  (2199)
1 site
G C T A G C C G A T C G
AmpR
3900 .. 4760  =  861 bp
286 amino acids  =  31.5 kDa
   Segment 2:  
   3900 .. 4691  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
3900 .. 4760  =  861 bp
286 amino acids  =  31.5 kDa
   Segment 1:  signal sequence  
   4692 .. 4760  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
3900 .. 4760  =  861 bp
286 amino acids  =  31.5 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
LTR
2169 .. 2762  =  594 bp
long terminal repeat from Moloney murine leukemia
virus
LTR
2169 .. 2762  =  594 bp
long terminal repeat from Moloney murine leukemia
virus
ori
3134 .. 3722  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
ori
3134 .. 3722  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
LTR (truncated)
8 .. 479  =  472 bp
long terminal repeat from Moloney murine leukemia
virus
LTR (truncated)
8 .. 479  =  472 bp
long terminal repeat from Moloney murine leukemia
virus
gag (truncated)
934 .. 1350  =  417 bp
truncated MMLV gag gene lacking the start codon
gag (truncated)
934 .. 1350  =  417 bp
truncated MMLV gag gene lacking the start codon
BleoR
1749 .. 2123  =  375 bp
124 amino acids  =  13.8 kDa
Product: antibiotic-binding protein
confers resistance to bleomycin, phleomycin, and
Zeocin™
BleoR
1749 .. 2123  =  375 bp
124 amino acids  =  13.8 kDa
Product: antibiotic-binding protein
confers resistance to bleomycin, phleomycin, and
Zeocin™
SV40 promoter
1413 .. 1742  =  330 bp
SV40 enhancer and early promoter
SV40 promoter
1413 .. 1742  =  330 bp
SV40 enhancer and early promoter
MMLV Ψ
542 .. 741  =  200 bp
packaging signal of Moloney murine leukemia virus
(MMLV)
MMLV Ψ
542 .. 741  =  200 bp
packaging signal of Moloney murine leukemia virus
(MMLV)
AmpR promoter
4761 .. 4865  =  105 bp
AmpR promoter
4761 .. 4865  =  105 bp
MCS
1355 .. 1402  =  48 bp
multiple cloning site
MCS
1355 .. 1402  =  48 bp
multiple cloning site
splice donor mutation
541 .. 541  =  1 bp
T-to-C mutation that blocks RNA splicing
splice donor mutation
541 .. 541  =  1 bp
T-to-C mutation that blocks RNA splicing
SV40 ori
1593 .. 1728  =  136 bp
SV40 origin of replication
SV40 ori
1593 .. 1728  =  136 bp
SV40 origin of replication
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2016 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter